17i-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GP30
Revision as of 02:47, 15 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == 17i-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GP30; A Vivacqua, D Bonofiglio, L Albanito, A Madeoae; 2006; doi_citing_unknown == Retraction == c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells ; Sarah Kraus Outhiriaradjou Benard Zvi Naor Rony Seger; 05...")
Target Article[edit | edit source]
17i-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GP30; A Vivacqua, D Bonofiglio, L Albanito, A Madeoae; 2006; doi_citing_unknown
Retraction[edit | edit source]
c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells ; Sarah Kraus Outhiriaradjou Benard Zvi Naor Rony Seger; 05/15/2003
Citation piece[edit | edit source]
Note: Open to append information.